MedTech Dive June 16, 2023
Dive Brief:
- A wrist-worn wearable could provide early warning of the severe acute pain episodes that affect patients with sickle cell disease.
- Researchers at Children’s Hospital Los Angeles (CHLA) tested the idea that the narrowing of blood vessels predicts the events in a clinical trial that reported data in 2019. They partnered with Biostrap to develop the blood flow biomarker that year.
- Biostrap, which sells a wearable that measures changes in blood volume, issued a statement about the collaboration ahead of World Sickle Cell Day on June 19.
Dive Insight:
In recent years, a team at CHLA has worked to validate the idea that the pain crises experienced by people with sickle cell disease are driven by...
Today's Sponsors
Today's Sponsor